Eosinophilic Esophagitis | CHOP Research Institute

Eosinophilic Esophagitis

A study to investigate changes of symptoms and esophageal cell structure with tezepelumab compared with placebo in patients aged 12 to 80 years old with eosinophilic esophagitis.
Published on
Aug 4, 2023
Find out how CHOP researchers create a valuable impact on children’s health in the PolicyLab 2023 Impact Report and more in this week’s research news roundup.
Published on
Aug 3, 2023
Our August Featured Research Trainee is Megha Lal, PhD, who investigates the mechanism of less common forms of food allergies such as eosinophilic esophagitis.
Published on
May 17, 2023
Terri Brown-Whitehorn, MD, a food allergy clinical researcher for over 25 years, values being part of research families’ lives and seeing firsthand the impact of her work.
Published on
Jan 6, 2023
See highlights of work by Children’s Hospital of Philadelphia researchers that is leading to novel findings.

Dr. Ruchelli is an attending pathologist with the Congenital Hyperinsulinism Center and the Division of Anatomic Pathology at CHOP, and an associate professor of pathology and laboratory medicine at the University of Penn. His research focuses on congenital hyperinsulinism and eosinophilic esophagitis.

ruchelli [at] chop.edu
Published on
May 25, 2022
Elizabeth Bhoj, MD, PhD, and David Hill, MD, PhD, are recipients of a 2021 Individual Biomedical Research Award from The Hartwell Foundation.

Dr. Merves has a background in basic and clinical translational research in eosinophilic esophagitis. Her more recent focus is clinical research in the pediatric short-bowel population. Dr. Merves is currently evaluating blenderized feeding in the pediatric short bowel population.

gilbergj [at] chop.edu

The main objective of this study is to see if repeat subcutaneous doses of dupilumab, the study medicine, helps to reduce eosinophilic inflammation in the stomach of participants with eosinophilic gastritis/ eosinophilic gastroenteritis compared to a placebo.

Published on
Nov 26, 2021
Learn about novel findings and new funding from our Children’s Hospital of Philadelphia researchers.